| Financial Year |
March 31 2023 |
| Monetary Funds |
1,232,997,259.29 |
| Held-for-trading Financial Assets |
1,810,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
424,072,100.48 |
| Advances to Suppliers |
53,162,312.52 |
| Other Receivables |
28,731,841.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
210,832,428.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,197,858.05 |
| Total Current Assets |
3,789,221,516.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
139,464,100.67 |
| Investment Properties |
-- |
| Fixed Assetes |
58,161,921.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,312,034.05 |
| R&D expenses |
11,412,262.22 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,243,815.77 |
| Deferred Income Tax Assets |
8,875,450.34 |
| Other Non-Current Assets |
9,235,578.82 |
| Sub-Total of Non-Current Assets |
1,372,618,648.93 |
| Total Assets |
5,161,840,165.36 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
112,161,206.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
68,562,618.13 |
| Taxes Payable |
23,865,612.58 |
| Interest Payable |
-- |
| Dividend Payable |
1,067,780.31 |
| Other payables |
59,862,433.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
120,772,838.57 |
| Other Current Liabilities |
33,337,842.28 |
| Sub-Total of Current Liabilities |
1,027,425,274.40 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
188,169,115.17 |
| Total Liabilities |
1,215,594,389.57 |
| Paid-In Capital(Or Share Stock) |
1,105,691,056.00 |
| Capital Surplus |
834,629,595.04 |
| Surplus Reserve |
271,506,142.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,412,216,665.94 |
| Minority Stockholder's Interest |
343,659,177.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,602,586,598.05 |
| Owner's Equity（Stockholder's Equity） |
3,946,245,775.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,161,840,165.36 |
